ClinicalTrials.Veeva

Menu

Risk of NSAIDs on Anastomotic Leak for Rectal Surgery

T

Third Military Medical University

Status

Completed

Conditions

Anti-Inflammatory Agents, Non-Steroidal
Anastomotic Leak

Treatments

Drug: NSAIDs

Study type

Observational

Funder types

Other

Identifiers

NCT06155175
20230804

Details and patient eligibility

About

Conflicting reports of the association between early postoperative non-steroidal anti-inflammatory drugs (NSAIDs) administration and anastomotic leak (AL) after rectal surgery have continued. The definition of AL and the exposure of NSAIDs differ from each other among studies, which may result in the different conclusions.

The aim of this retrospective study was to clarify the effect of NSAIDs on anastomotic leak from new angels.

Full description

Concerning about the side effects induced by opioids, nonsteroidal anti-inflammatory drugs (NSAIDs) have gained its popularity in ERAS protocols. NSAIDs competitively inhibits the activity of cyclooxygenases (COXs), which are involved in migration of epithelial cell and mucosal restitution, angiogenesis and collagen synthesis during healing. Conflicting reports of the association between early postoperative non-steroidal anti-inflammatory drugs (NSAIDs) administration and anastomotic leak (AL) after rectal surgery have continued.

Notably, the definition of AL and the exposure of NSAIDs (i.e. NSAIDs administration) differ from each other among the studies, which may result in the different conclusions. In concrete terms, the definition of NSAIDs administration timing varies from the first day to the first week after surgery, while the AL was also defined in multiple ways (timing varies from 14 to 90 days postoperatively, or only leaks with operative intervention included). Most previous studies suggested that early and late AL are different entities with different risk factors. These interesting evidences indicate reconsidering the effect of NSAIDs on AL is needed.

Hence, investigators defined the NSAIDs administration as at least once in the early postoperative period--the day of and the day after surgery (NSAID group), to avoid the inclusion of patients started on NSAIDs secondary to a complication. At the same time, investigators also classified AL into early AL (confirmed within 6 days) and late AL (over 6 days). Moreover, concerning the higher rate of AL in rectal surgery than colonic surgery and the trend of minimally invasive surgery, investigators performed the current study, aiming to clarify the association between early postoperative NSAIDs and anastomotic leak in rectal surgery.

Enrollment

1,969 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Biopsy-proven adenocarcinoma of the rectum
  • Age over 18 years old
  • Patients underwent non-emergency minimally invasive surgery with a primary anastomosis

Exclusion criteria

  • Incomplete medical records
  • Patients with distant metastasis before surgery
  • Patients with multiple primary colorectal carcinomas

Trial design

1,969 participants in 2 patient groups

NSAIDs
Description:
patients were treated with NSAIDs postoperatively
Treatment:
Drug: NSAIDs
No-NSAIDs
Description:
patients were not treated with NSAIDs postoperatively

Trial contacts and locations

1

Loading...

Central trial contact

WeiDong Tong, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems